Concepedia

Naresh Bumma

NB

Statistics

Publications

34

Citations

1.9K

H-Index

18

Active since

2017

Affiliations

The Ohio State University(Current)

The University of Texas MD Anderson Cancer Center

Emory University

Moffitt Cancer Center

Icahn School of Medicine at Mount Sinai

Naresh Bumma is an author at The Ohio State University specializing in immunotherapy, multiple myeloma, and medicine.

Publications per year

2017–2024

34

Publications

34

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

, , +15

Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA

Giovanni Palladini, Efstathios Kastritis, Mathew S. Maurer et al. · Blood · 2020 · 208 citations · Full text

, , +3

Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial

Peter M. Voorhees, Douglas W. Sborov, Jacob P. Laubach et al. · The Lancet Haematology · 2023 · 153 citations

, , +16

Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

Naresh Bumma, Joshua Richter, Sundar Jagannath et al. · Journal of Clinical Oncology · 2024 · 135 citations · Full text

, , +16

Neutrophil lymphocyte ratio and duration of prior anti-angiogenic therapy as biomarkers in metastatic RCC receiving immune checkpoint inhibitor therapy

Ghayathri Jeyakumar, Seongho Kim, Naresh Bumma et al. · Journal for ImmunoTherapy of Cancer · 2017 · 102 citations · Full text

, , +17

1–5 of 34